A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Evaluate the efficacy and safety of Apatinib (500mg/d) with gemcitabine(1000mg/m2) in advanced metastatic pancreatic cancer.
Epistemonikos ID: 36aef4360d900f0c5803597918ed3e907200d0d4
First added on: May 17, 2024